openPR Logo
Press release

XClinical embarks on collaborative effort with BALT International

03-30-2010 11:50 AM CET | Health & Medicine

Press release from: XClinical GmbH

XClinical embarks on collaborative effort with BALT

XClinical GmbH starts cooperation with French Medical Device Company BALT International

XCLINICAL GMBH, Munich, Germany – 29 March, 2010 – XClinical, a European vendor of software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, announced today that BALT International, a French Medical Device company, has decided to use XClinical’s EDC Software MARVIN.

BALT will soon start using the software solution in a two-year neurovascular trial. One hundred and sixty patients will be enrolled in the study to investigate intracranial aneurysm. Apart from randomisation, a blinded review of data will also be conducted with MARVIN during the study. Flexible roles and permissions within the system will be used to enable e.g. the anonymous review of angiographic images. Another feature of this trial shall be its integration of a validated “quality of life” questionnaire. “We are proud to sponsor the MARCO POLO trial and we wanted to have the best EDC solution to allow the trial to run smoothly,” said Nicolas Plowiecki, CEO of BALT International. “We are happy to have started our collaboration with MARVIN, it seemed like a tailor-made solution for this project.”

From the initial contact made between BALT International and XClinical, it only took a few months until the “first patient-in”. “BALT International is the second client within the past few months with such a short set-up time,” said Dr Claus Lindenau from XClinical. “This underlines the advantages of an ODM metadata-driven set-up process.”

The short set-up time was one of BALT’s main reasons to decide on the German vendor’s solution. “It is critical that the investigators have an easy, user-friendly interface to input patients’ data quickly and intuitively,” stated Linda Nicolini, Director of Market Development at BALT Extrusion. ”We found MARVIN to meet those needs.”

About XClinical
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM-certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM).

About BALT International
BALT International (www.balt.fr), founded in 1978 in Montmorency/France, designs, develops, manufactures and markets innovative medical devices for the treatment of neuro-vascular diseases. Its latest products include stents, balloons and catheters marketed under the names of SILK, LEO+, VASCO+, SONIC and MAGIC, to name but a few.

XClinical GmbH
Katharina Lang
Siegfriedstraße 8
80803 Munich/Germany
+49/(0)89 452277 5220
press@xclinical.com
www.xclinical.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release XClinical embarks on collaborative effort with BALT International here

News-ID: 125266 • Views:

More Releases from XClinical GmbH

XClinical integrates INCA, Medical Coding software, with its EDC system MARVIN
XClinical releases version 1.6. of its coding system INCA XClinical GmbH, Munich, Germany, May 8, 2014 – XClinical, a global provider of eClinical solutions, today announces the availability of INCA version 1.6, medical coding software featuring MedDRA and WHODrug dictionaries, including an automated web interface to EDC systems such as MARVIN. INCA (“Integrated Coding Architecture”) is a web-based application that enables users to classify health related data such as patient medications and
XClinical CRO Executive Forum
XClinical CRO Executive Forum
XClinical hosts its first CRO Executive Forum on May 10, 2011 in Aying, Germany. XClinical GmbH, Munich, Germany – April 14, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, hosts its first CRO Executive Forum especially designed for CEOs of CROs on May 10, 2011 in Aying, Germany. The concept In 2010, XClinical started to provide
XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical presents the initiative “MARVIN4KIDS” at the DIA Annual EuroMeeting in Geneva XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the initiative “MARVIN4KIDS” for the first time at the DIA Annual EuroMeeting in Geneva. The conference takes place from March 28 to 30. “MARVIN4KIDS” MARVIN4KIDS is an XClinical
XClinical and IDDI: The best of 2 worlds
XClinical and IDDI: The best of 2 worlds
The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the web-based open interface of IDDI’s ID-netTM to XClinical’s EDC system MARVIN at the DIA Annual EuroMeeting in Geneva. About ID-netTM ID-netTM

All 5 Releases


More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical